the additional use of cryopreservation technology could increase the range and practicality of cell sheet therapies.
there is considerable interest in using cell sheets for the treatment of various lesions as part of regenerative medicine therapy.
cell sheets can be prepared in temperature-responsive culture dishes and applied to injured tissue.
for example, cartilage-derived cell sheets are currently under preclinical testing for use in treatment of knee cartilage injuries.
to date, however, cryopreservation of cell sheets has proved impractical.
we modified the vitrification method previously developed for cryopreservation of mammalian embryos to vitrify a cell sheet through use of a minimum volume of vitrification solution containing 20% dimethyl sulfoxide, 20% ethylene glycol,  <dig> Â m sucrose, and 10% carboxylated poly-l-lysine.
the principal feature of our method is the coating of the cell sheet with a viscous vitrification solution containing permeable and non-permeable cryoprotectants prior to vitrification in liquid nitrogen vapor.
this method prevented fracturing of the fragile cell sheet even after vitrification and rewarming.
both the macro- and microstructures of the vitrified cell sheets were maintained without damage or loss of major components.
we have shown here that it is feasible to vitrify chondrocyte cell sheets and that these sheets retain their normal characteristics upon thawing.
the availability of a practical cryopreservation method should make a significant contribution to the effectiveness and range of applications of cell sheet therapy.
